- Corporate Officers - G
- Galbraith Kenneth
Insider Trading History of Galbraith Kenneth
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Galbraith Kenneth since 2013.
This trader's CIK number is 1567045.
At the time of last reporting, Galbraith Kenneth was the Chair & CEO of Zymeworks Inc.. (stock ticker symbol ZYME).
Also see all insider trading activities at Zymeworks Inc..
Note that in the past
Galbraith Kenneth also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Zymeworks Inc. (ZYME) by Galbraith Kenneth
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ZYME | 0 | $0 | 57,291 | $855,010 | 114,332 | $0 |
| 2024 | ZYME | 0 | $0 | 23,904 | $257,843 | 47,666 | $0 |
Yearly summary of insider trading at Macrogenics Inc (MGNX) by Galbraith Kenneth
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | MGNX | 0 | $0 | 20,773 | $563,156 | 20,773 | $375,471 |
| 2013 | MGNX | 46,875 | $750,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Galbraith Kenneth:
1. Zymeworks Inc. (ZYME)
2. Macrogenics Inc (MGNX)
Table 1. Insider trading of Zymeworks Inc. (ZYME) by Galbraith Kenneth
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-01-06 | ZYME | Option Ex | 114,332 | .00 | 0 |
| 2025-01-06 | ZYME | Sale | 57,291 | 14.92 | 855,010 |
| 2024-01-08 | ZYME | Sale | 5,706 | 11.22 | 63,998 |
| 2024-01-05 | ZYME | Sale | 18,198 | 10.65 | 193,845 |
| 2024-01-05 | ZYME | Option Ex | 47,666 | .00 | 0 |
Table 2. Insider trading of Macrogenics Inc (MGNX) by Galbraith Kenneth
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-09-09 | MGNX | Sale | 20,773 | 27.11 | 563,156 |
| 2020-09-09 | MGNX | Option Ex | 20,773 | 18.07 | 375,471 |
| 2013-10-16 | MGNX | Buy | 46,875 | 16.00 | 750,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Galbraith Kenneth
(Chair & CEO of Zymeworks Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.